A review of applications of tea tree oil in dermatology

International Journal of Dermatology

Volumn 52, Issue 7, 2013, Pages 784-790

  Pazyar, Nader ^a   Yaghoobi, Reza ^a   Bagherani, Nooshin ^a   Kazerouni, Afshin ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

TEA TREE OIL; TOPICAL ANTIINFECTIVE AGENT;

ACNE VULGARIS; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; CHEMICAL COMPOSITION; CONTACT DERMATITIS; DERMATOLOGY; DRUG HYPERSENSITIVITY; ERYTHEMA; GINGIVITIS; GYNECOMASTIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEBORRHEIC DERMATITIS; SKIN ALLERGY; SKIN IRRITATION; WOUND HEALING; CHEMISTRY; SKIN DISEASES;

ANTI-INFECTIVE AGENTS, LOCAL; HUMANS; SKIN DISEASES; TEA TREE OIL;

EID: 84879798917     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.05654.x     Document Type: Review

References (47)

1. Teissedre PL, Waterhouse AL. Inhibition of oxidation of human low-density lipoproteins by phenolic substances in different essential oils varieties. J Agric Food Chem 2000; 48: 3801-3805.
2. Halm MA. Essential oils for management of symptoms in critically ill patients. Am J Crit Care 2008; 17: 160-163.
3. Pazyar N, Yaghoobi R. Tea tree oil as a novel antipsoriasis weapon. Skin Pharmacol Physiol 2012; 25: 162-163.
4. Mantle D, Gok MA, Lennard TW. Adverse and beneficial effects of plant extracts on skin and skin disorders. Adverse Drug React Toxicol Rev 2001; 20: 89-103.
5. Greay SJ, Ireland DJ, Kissick HT, et al. Inhibition of established subcutaneous murine tumor growth with topical Melaleuca alternifolia (tea tree) oil. Cancer Chemother Pharmacol 2010; 66: 1095-1102.
6. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analysis of studies that evaluate health care interventions: explanation and elaboration. Ital J Public Health 2009; 6: 354-391.
7. Papadopoulos CJ, Carson CF, Chang BJ, Riley TV. Role of the MexAB-OprM efflux pump of Pseudomonas aeruginosa in tolerance to tea tree (Melaleuca alternifolia) oil and its monoterpene components terpinen-4-ol, 1, 8-cineole, and alpha-terpineol. Appl Environ Microbiol 2008; 74: 1932-1935.
8. Mondello F, De Bernardis F, Girolamo A, et al. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. BMC Infect Dis 2006; 6: 158.
9. Homer LE, Leach DN, Lea D, et al. Natural variation in the essential oil content of Melaleuca alternifolia Cheel (Myrtaceae). Biochem Syst Ecol 2000; 28: 367-382.
10. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 2006; 19: 50-62.
11. Hammer KA, Carson CF, Riley TV, Nielsen JB. A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol 2006; 44: 616-625.
12. Crawford GH, Sciacca JR, James WD. Tea tree oil: cutaneous effects of the extracted oil of Melaleuca alternifolia. Dermatitis 2004; 15: 59-66.
13. Henley DV, Korach KS. Physiological effects and mechanisms of action of endocrine disrupting chemicals that alter estrogen signaling. Hormones 2010; 9: 191-205.
14. Kim HJ, Chen F, Wu C, et al. Evaluation of antioxidant activity of Australian tea tree (Melaleuca alternifolia) oil and its components. J Agric Food Chem 2004; 52: 2849-2854.
15. Khalil Z, Pearce AL, Satkunanathan N, et al. Regulation of wheal and flare by tea tree oil: complementary human and rodent studies. J Invest Dermatol 2004; 123: 6836-6890.
16. Brand C, Townley SL, Finlay-Jones JJ, Hart PH. Tea tree oil reduces histamine-induced edema in murine ears. Inflamm Res 2002; 51: 283-289.
17. Koh KJ, Pearce AL, Marshman G, et al. Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol 2002; 147: 1212-1227.
18. Loughlin R, Gilmore BF, McCarron PA, Tunney MM. Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells. Lett Appl Microbiol 2008; 46: 428-433.
19. Thompson G, Blackwood B, McMullan R, et al. A randomized controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonization with methicillin-resistant Staphylococcus aureus (MRSA) in critically ill adults: research protocol. BMC Infect Dis 2008; 8: 161.
20. Kunicka-Styczyńska A, Sikora M, Kalemba D. Lavender, tea tree and lemon oils as antimicrobials in washing liquids and soft body balms. Int J Cosmet Sci 2011; 33: 53-61.
21. Soukoulis S, Hirsch R. The effects of a tea tree oil-containing gel on plaque and chronic gingivitis. Aust Dent J 2004; 49: 78-83.
22. Schnitzler P, Schön K, Reichling J. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Pharmazie 2001; 56: 343-347.
23. Carson CF, Ashton L, Dry L, et al. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J Antimicrob Chemother 2001; 48: 450-451.
24. Millar BC, Moore JE. Successful topical treatment of hand warts in a pediatric patient with tea tree oil (Melaleuca alternifolia). Complement Ther Clin Pract 2008; 14: 225-227.
25. Hammer K, Carson C, Riley T. In vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J Antimicrob Chemother 1998; 42: 591-595.
26. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Australas J Dermatol 2002; 43: 175-178.
27. Syed TA, Qureshi ZA, Ali SM, et al. Treatment of toenail with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health 1999; 4: 284-287.
28. Buck DS, Nidorf DM, Addino JG. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract 1994; 38: 601-605.
29. Van de Sande WW, Fahal AH, et al. In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. J Antimicrob Chemother 2007; 59: 553-555.
30. Mikus J, Harkenthal M, Steverding D, Reichling J. In vitro effect of essential oils and isolated mono- and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med 2000; 66: 366-368.
31. Walton SF, Myerscough MR, Currie BJ. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans R Soc Trop Med Hyg 2000; 94: 92-96.
32. Walton SF, McKinnon M, Pizzutto S, et al. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of Sarcoptes scabiei var. hominis to terpinen-4-ol. Arch Dermatol 2004; 140: 563-566.
33. Mills C, Cleary BJ, Gilmer JF, Walsh JJ. Inhibition of acetylcholinesterase by tea tree oil. J Pharm Pharmacol 2004; 56: 375-379.
34. Barker SC, Altman PM. A randomized, assessor blind, parallel group comparative efficacy trial of three products for the treatment of head lice in children - melaleuca oil and lavender oil, pyrethrins and piperonyl butoxide, and a "suffocation" product. BMC Dermatol 2010; 10: 6.
35. Gao YY, Di Pascuale MA, Li W, et al. In vitro and in vivo killing of ocular Demodex by tea tree oil. Br J Ophthalmol 2005; 89: 1468-1473.
36. Gao YY, Di Pascuale MA, Elizondo A, Tseng SC. Clinical treatment of ocular demodecosis by lid scrub with tea tree oil. Cornea 2007; 26: 136-143.
37. Enshaieh S, Jooya A, Siadat AH, Iraji F. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol 2007; 73: 22-25.
38. Martin KW, Ernst E. Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother 2003; 51: 241-246.
39. Bassett IB, Pannowitz DL, Barnetson RS. A comparative study of tea tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990; 153: 455-458.
40. Gupta AK, Nicol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol 2004; 5: 417-422.
41. Waldroup W, Scheinfeld N. Medicated shampoos for the treatment of seborrheic dermatitis. J Drugs Dermatol 2008; 7: 699-703.
42. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of dandruff with 5% tea tree oil shampoo. J Am Acad Dermatol 2002; 47: 852-855.
43. Woollard AC, Tatham KC, Barker S. The influence of essential oils on the process of wound healing: a review of the current evidence. J Wound Care 2007; 16: 255-257.
44. Jandera V, Hudson DA, de Wet PM, et al. Cooling the burn wound: evaluation of different modalities. Burns 2000; 26: 265-270.
45. Giordani C, Molinari A, Toccacieli L, Calcabrini A, et al. Interaction of tea tree oil with model and cellular membranes. J Med Chem 2006; 49: 4581-4588.
46. Bozzuto G, Colone M, Toccacieli L, et al. Tea tree oil might combat melanoma. Planta Med 2011; 77: 54-56.
47. Saxer UP, Stäuble A, Szabo SH, Menghini G. Effect of mouthwashing with tea tree oil on plaque and inflammation. Schweiz Monatsschr Zahnmed 2003; 113: 985-986.